Whenever I’m working with an organization assessing new technology against (or in tandem with) old infrastructure, I recommend the following steps to ensure success.
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback